The Veradigm board of directors has completed its previously announced review of strategic alternatives, which involved more than 30 parties and included a possible sale, the company said Thursday. Despite attracting five bidders with preliminary…
Continue Reading
Ohad Peled, Product Marketing Manager at Sony Semiconductor Israel
The global home medical equipment market is experiencing explosive growth. Smart devices are being used to monitor and treat patients suffering from diabetes, cardiac disorders, and…
Continue Reading
What You Should Know:
– Cognizant (Nasdaq: CTSH) announced an expanded agreement with Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, to provide support for Medidata’s life sciences clients and expand the…
Continue Reading
What You Should Know:
– Owkin, an AI-powered biotech company, today announced the dosing of the first patient in its Phase I clinical trial of OKN4395, a novel cancer therapy designed to restore immune function…
Continue Reading
What You Should Know:
– ActiGraph, the global leader in wearable digital health technology for clinical research and drug development, and Hyfe Inc., the pioneer in AI-powered cough detection technology, have announced the release of their…
Continue Reading
What You Should Know:
– Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease with its novel PULSE IVL™ platform, announced today that it has completed a…
Continue Reading
Brunel University is leading a project which aims to improve regulation to bring more AI-powered healthcare products to the UK, such as diagnostics, smartphone apps and devices which predict and treat ill health.
It is…
Dr. Rakesh Nagarajan is the Chief Medical Officer at Velsera
The healthcare industry is experiencing a data and technological revolution that is accelerating drug discovery and delivery to patients. Over the past 15 years, we’ve…
Continue Reading
Neurotechnology company, Grey Matter Neurosciences, announced it secured $14 million in seed financing, which will be used to develop an ultrasound headset for individuals with Alzheimer’s disease and test that device in clinical trials.The…
Continue Reading
What You Should Know:
– Inato, the leading platform for clinical trial access and inclusivity, today unveiled new capabilities to help research sites efficiently pre-screen patients for trial opportunities.
– The company’s latest advancement integrates a…
Continue Reading
